Skip to main content
. 2015 Feb 4;6:11. doi: 10.3389/fneur.2015.00011

Figure 2.

Figure 2

Average (mean ± 1 SD) headache severity on four-point scale at before treatment, 2 h post treatment, and 24 h post treatment (all 25 completers). Wilcoxon sign-rank tests show significant reductions in pain intensity at both 2 h (p = 0.029) and 24 h (p < 0.001).